Potassium Hydroxide → HCID 86755693, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([CH2:9][C@H:10]2[CH2:15][C@H:14]([NH:16][C:17]3[N:21]([CH2:22][CH2:23][O:24][CH2:25][CH3:26])[C:20]4[CH:27]=[CH:28][CH:29]=[CH:30][C:19]=4[N:18]=3)[CH2:13][CH2:12][N:11]2C(OCC)=O)[CH:5]=[CH:6][C:7]=1[Cl:8].[OH-].[K+]>CC(O)C>[Cl:1][C:2]1[CH:3]=[C:4]([CH2:9][C@H:10]2[CH2:15][C@H:14]([NH:16][C:17]3[N:21]([CH2:22][CH2:23][O:24][CH2:25][CH3:26])[C:20]4[CH:27]=[CH:28][CH:29]=[CH:30][C:19]=4[N:18]=3)[CH2:13][CH2:12][NH:11]2)[CH:5]=[CH:6][C:7]=1[Cl:8]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of (±)-ethyl trans-2-[(3,4-dichlorophenyl)methyl]-4-[[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]amino]-1-piperidinecarboxylate (2.5 g) and KOH (2.8 g) in 2-propanol (50 ml) was stirred and refluxed for 48 hours. The solvent was evaporated. The residue was partitioned between water and CH2Cl2. The organic layer was separated, dried, filtered and the solvent evaporated. The residue was purified by column chromatography over silica gel (eluent: CH2Cl2 /(CH3OH/NH3) 95/5, upgrading to 90/10). The pure fractions were collected and the solvent was evaporated, yielding 1.1 g (49.2%) of (±)-trans-N-[2-[(3,4-dichlorophenyl)methyl]-4-piperidinyl]-1-(2-ethoxyethyl)-1H-benzimidazol-2-amine (interm. 28).
Workup
- temperaturerefluxed for 48 hours
- customThe solvent was evaporated
- customThe residue was partitioned between water and CH2Cl2
- customThe organic layer was separated
- customdried
- filtrationfiltered
- customthe solvent evaporated
- customThe residue was purified by column chromatography over silica gel (eluent: CH2Cl2 /(CH3OH/NH3) 95/5, upgrading to 90/10)
- customThe pure fractions were collected
- customthe solvent was evaporated
Sources & evidence
- ORD record
- ord-d90bda003d7a479083f2a4ca32f96d2b
- Source dataset
- uspto-grants-2000_08
- Patent number
- US06110939
Reaction notes
Loading…